Company Filing History:
Years Active: 2021-2025
Title: Geert Jan Van Tetering: Innovator in Engineered Antibodies
Introduction
Geert Jan Van Tetering is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. With a total of 3 patents to his name, his work has the potential to impact various medical treatments.
Latest Patents
Van Tetering's latest patents focus on engineered IgA antibodies and their methods of use. These patents describe engineered antibodies that comprise a modified IgA2 heavy chain constant region, along with pharmaceutical compositions and methods of use. The engineered antibodies include one or more amino acid substitutions or deletions in a constant region of an IgA2 domain, which modify naturally occurring glycosylation sites. Furthermore, these patents outline methods for treating disorders, including cancer, by administering the engineered IgA antibodies.
Career Highlights
Throughout his career, Geert Jan Van Tetering has worked with prominent organizations such as UMC Utrecht Holding B.V. and Tiga Tx, Inc. His experience in these companies has allowed him to advance his research and contribute to the field of antibody engineering.
Collaborations
Van Tetering has collaborated with esteemed colleagues, including Jeanette Henrica Wilhelmina Leusen and Johannes Gerardus Maria Evers. These collaborations have further enriched his research and development efforts in the biotechnology sector.
Conclusion
Geert Jan Van Tetering is a distinguished inventor whose work in engineered antibodies holds promise for future medical advancements. His contributions to biotechnology and collaborations with other experts highlight his commitment to innovation in the field.